CRS Bio


CRS Bio focuses on targeted delivery of antibodies for treatment of chronic rhinosinusitis (CRS) with and without nasal polyps, by utilizing ActoBiotics technology to block inflammatory mediators in the nasal passage, leading to improved breathing and, importantly, patients' quality of life.

CRS Bio focuses on targeted delivery of antibodies for treatment of chronic rhinosinusitis (CRS) with and without nasal polyps, by utilizing ActoBiotics technology to block inflammatory mediators in the nasal passage, leading to improved breathing an...Show all

Company (Alive / Active)

Phone: 415-835-3900

Fax:

600 Montgomery Street
Suite 1700
San Francisco, 94111
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CRS Bio $8.4M Sep 24, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CRS Bio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)